Cell therapy for chronic radiation-induced intestinal injury
Part of Digestive system clinical trials.
This study tests whether a new cell therapy can help people with long-term intestinal damage caused by pelvic or abdominal radiation. It aims to reduce symptoms like diarrhea, pain, or bleeding and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have had radiation therapy to your pelvis or abdomen
- You have been diagnosed with radiation-induced intestinal injury that started at least 3 months after radiation, confirmed by a colonoscopy
- Your symptoms are moderate to severe (grade 2–3) and have not improved after two weeks of standard treatments
- Your cancer has been under control for at least 3 months
- Your liver and kidney function tests are within acceptable limits
- You are willing to sign a consent form and follow the study plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests whether special cells from umbilical cord blood, called UCB-MNCs, can help repair lung damage caused by past radiation therapy to the chest. If you have not responded to usual treatments, this may be a new option to explore.
This trial tests a new stem cell treatment for chronic radiation proctitis, a condition where the rectum is damaged from radiation therapy. The study will see how these cells spread in your body and if they can help heal the damage.
This study looks at how radiation therapy affects the intestines and may help find ways to predict and manage side effects. By participating, you could help doctors better understand and treat radiation-related gut problems.
This trial tests a new cell therapy called CNK-UT009 for people with inflammatory bowel disease (like Crohn's or ulcerative colitis) that has been hard to treat. It may reduce inflammation and help you feel better.
This trial tests a shorter radiation course combined with two chemotherapy drugs and an immunotherapy drug for people with locally advanced rectal cancer that is microsatellite stable. The goal is to shrink the tumor before surgery, which may improve outcomes with fewer side effects.
This study tests if a traditional Chinese medicine formula (Gegen Qinlian Tang) plus probiotics can help people who have gut problems from radiation treatment for cancer. It may reduce diarrhea, pain, or other bowel symptoms caused by radiation.
Hear when a new Chronic Radiation Induced Intestinal Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.